Transcutaneous Auricular Vagal Nerve Stimulation Against Fatigue Syndrome in Patients with Long COVID: Results of the Randomized, Placebo-Controlled Clinical Pilot Trial COVIVA

Key Points

• To evaluate the efficacy of transcutaneous auricular vagal nerve stimulation on fatigue syndrome in long COVID patients.
• Conducted a randomized, placebo-controlled clinical trial
• Participants diagnosed with long COVID experiencing fatigue were enrolled
• Transcutaneous auricular vagal nerve stimulation was administered to one group while the other received a placebo
• The intervention group showed improvement in fatigue symptoms
• Statistical analysis indicated significant differences between the treatment and placebo groups